Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
E.W. Scripps
SSP
$258M
| $19.7M | ﹤0.01% |
965,569
+26,433
| +3% | +$554K |
|
1977
Customers Bancorp
CUBI
$2.72B
| $19.7M | ﹤0.01% |
504,070
+21,931
| +5% | +$790K |
|
1978
Upland Software
UPLD
$13.1M
| $19.6M | ﹤0.01% |
47,613
+3,455
| +8% | +$1.52M |
|
|
TUP
1979
DELISTED
Tupperware Brands Corporation
TUP
| $19.6M | ﹤0.01% |
823,463
+31,197
| +4% | +$791K |
|
1980
Butterfly Network
BFLY
$2.19B
| $19.5M | ﹤0.01% |
+1,348,659
| New | +$18.2M |
|
|
PFC
1981
DELISTED
Premier Financial Corp. Common Stock
PFC
| $19.5M | ﹤0.01% |
686,535
+33,581
| +5% | +$1.04M |
|
1982
Utz Brands
UTZ
$1.25B
| $19.5M | ﹤0.01% |
894,702
+486,172
| +119% | +$12.1M |
|
|
AIV
1983
Aimco
AIV
$387M
| $19.5M | ﹤0.01% |
2,904,729
+685,313
| +31% | +$4.71M |
|
1984
Vale
VALE
$62B
| $19.5M | ﹤0.01% |
854,026
+6,149
| +0.7% | +$129K |
|
|
TGI
1985
DELISTED
Triumph Group
TGI
| $19.4M | ﹤0.01% |
937,077
+103,787
| +12% | +$1.91M |
|
|
AAN
1986
DELISTED
The Aaron's Company Inc
AAN
| $19.4M | ﹤0.01% |
606,855
-21,387
| -3% | -$674K |
|
|
GCP
1987
DELISTED
GCP Applied Technologies Inc.
GCP
| $19.3M | ﹤0.01% |
830,010
+45,736
| +6% | +$1.13M |
|
1988
Madrigal Pharmaceuticals
MDGL
$11.1B
| $19.3M | ﹤0.01% |
198,104
+43,308
| +28% | +$5.13M |
|
1989
Matthews International
MATW
$876M
| $19.3M | ﹤0.01% |
536,248
+18,632
| +4% | +$744K |
|
|
CERE
1990
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $19.3M | ﹤0.01% |
752,427
+308,636
| +70% | +$4.42M |
|
1991
BJ's Restaurants
BJRI
$1.44B
| $19.3M | ﹤0.01% |
392,227
+18,629
| +5% | +$1.03M |
|
1992
Standex International
SXI
$3.78B
| $19.2M | ﹤0.01% |
202,714
+2,343
| +1% | +$227K |
|
1993
Huron Consulting
HURN
$2.39B
| $19.2M | ﹤0.01% |
390,517
+6,844
| +2% | +$368K |
|
1994
The Joint Corp
JYNT
$117M
| $19.1M | ﹤0.01% |
227,547
+4,202
| +2% | +$261K |
|
|
VNE
1995
DELISTED
Veoneer, Inc.
VNE
| $19M | ﹤0.01% |
826,288
+37,355
| +5% | +$888K |
|
1996
National Bank Holdings
NBHC
$1.92B
| $19M | ﹤0.01% |
504,068
+8,553
| +2% | +$339K |
|
|
HSII
1997
DELISTED
Heidrick & Struggles
HSII
| $19M | ﹤0.01% |
426,865
+8,492
| +2% | +$355K |
|
1998
Nice
NICE
$5.9B
| $19M | ﹤0.01% |
76,709
+2,009
| +3% | +$463K |
|
|
DCH
1999
Dauch Corp
DCH
$1.38B
| $19M | ﹤0.01% |
1,831,815
-30,220
| -2% | -$318K |
|
2000
LeMaitre Vascular
LMAT
$2.37B
| $18.9M | ﹤0.01% |
310,569
+18,009
| +6% | +$957K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.